INTRODUCTION
A large-scale population-based cohort study is a desirable means of elucidating risk factors for cancer and cardiovascular diseases. Often, it takes more than 10 years for these chronic degenerative diseases to become clinically detectable. Beginning in 1965, Soda, Hirayama and coworkers 1) followed a cohort of 265,000 subjects in 29 public health center areas of six prefectures in Japan. They found significant relationships between smoking and cancer and other diseases and a significant preventive effect of consuming green and yellow vegetables on cancer mortality. This cohort study had several methodological advantages, such as high response rate (approximately 95%) and low migration rate (8% for 17 years), however, the simplicity of the questionnaire caused several major limitations: participants were surveyed regarding only seven food items, green tea temperature preference, and smoking and alcohol use habits. Moreover, there have been drastic changes in lifestyle among the Japanese population during these decades, which makes lifestyle observed at baseline in this original cohort difficult to apply to the current Japanese population. The necessity of a new population-based prospective study was thus recognized and the Japan Public Health
Center-based Prospective Study on Cancer and Cardiovascular Diseases (JPHC Study) was launched.
The study aims to clarify risk and preventive factors for cancer and cardiovascular diseases by a large-scale populationbased prospective study. Furthermore, the obtained results will be useful for the future promotion of good health in Japan.
METHODS

Study cohorts
Between 1989 and 1991, the Epidemiology Division of the National Cancer Center Research Institute conducted a crosssectional study, randomly selecting men aged 40 to 59 years and their wives from the general population in the territories of five public health centers in Ninohe (Iwate prefecture), Yokote (Akita prefecture), Saku (Nagano prefecture), Ishikawa (Okinawa prefecture), and Katsushika-kita (Tokyo metropolis). Blood and urine samples were collected and the applicability of biological markers to epidemiological research was heavily investigated z,s). Based on the experience of this cross-sectional study and with the cooperation of each public health center, cohorts consisting of 40-to 59-year-old residents were estab-
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Design and Organization of JPHC Study lished in each public health center area at the end of 1989, and the baseline survey and follow-up were started in 1990. This group became known as cohort I. The primary purpose was to identify cancer risk factors with a protocol that incorporated health screening data and blood storage for future study. Cohort II was added to the study in 1992, and data collection started in 1993. Similar data was collected from this cohort, but expanded to detect risk factors of both cancer and cardiovascular diseases. Six public health centers in Kashiwazaki (Niigata prefecture), Kasama (Ibaraki prefecture), Tosayamada (Kochi prefecture), Arikawa (Nagasaki prefecture), Miyako (Okinawa prefecture), and Suita (Osaka prefecture) joined the study.
Organization
A study protocol was developed by the research members of the JPHC Study and authorized by the Ministry of Health and Welfare. The organization of the JPHC Study Group is listed in Table 1 . Due to the different starting dates, the operating committees for cohort I and cohort II were separately organized, but they communicate closely with each other. A Steering Board Committee was instituted to manage and control the progress of the whole study, and an Advisory Board Committee and consultants helped the progress. To use the health checkup data from each study area, standardization of laboratory data was planned by the Standardization Committee. A Nutritional Study Committee was set up to focus on dietary assessment of the participants and evaluate the validity of the assessment method. Annual meetings with relevant offices in the Ministry of Health and Welfare are also held.
Study subjects
Basically, all the residents within the age range 40-59 years, or 40-69 for cohort II, living in the city and town in each public health center area were selected as candidates. The location of the study areas and number of study subjects are shown in Figure 1 . A total of 140,409 subjects were included based on municipality resident registry of 29 districts in the territories of 11 public health centers.
Cohort I: All residents, aged between 40 and 59 years on December 31, 1989, in the following areas were registered as the subjects for the study: Ninohe Public Health Center were also obtained at this time.
Follow-up system
The study subjects will be followed up for mortality , migration, Migration: Each public health center reports every migration from an original address to a coordinating center by referring to each local government annually with information of new addresses. The coordinating center refers to those new addresses every four years thereafter.
Incidence of cancer and cardiovascular diseases: To collect incidence data of cancer and cardiovascular disease, two data sources are used: one from the local major hospital and the other from a population-based registry (usually prefecturewide). In some areas, major hospitals care for most cancer or cardiovascular patients (up to 80%). These hospitals are listed on death certificates. Then local major hospitals are considered as the primary data source, and clinical information is extracted from medical records into cohort-specific registration forms either by physicians in the hospital or physicians in the public health center. In this case, the population-based registry is used as a supplemental data source, if available. In those areas where local hospitals cannot cover a sufficiently high proportion of cancer or cardiovascular patients, data from local hospitals and population-based registry are considered equally as primary data sources. In this case, if the quality of the population-based registry is not high, additional activities are encouraged to improve the quality within the cohort subjects.
Quality of registration within the cohort is monitored in all study areas using several indices: O/E ratio (observed versus expected ratio), I/D ratio (incidence versus mortality ratio), Second, study subjects consist of all residents in defined Newsletter Regular distribution of a newsletter to the study subjects is planned to inform them of the progress of the JPHC study and to provide health education. The coordinating center will prepare the central version that includes general findings and news. Each public health center will also prepare a local version. The time schedule of newsletter distribution will depend on the progress of the study. comparison more powerful to detect significant associations. Fourth, blood samples were collected and stored for the future use. This is particularly important because bacterial or viral infection, such as helicobacter pylori, hepatitis C virus, human papillomavirus, and human T-cell leukemia/lymphoma virus I are major risk factors for cancer. Also, biochemical substances in blood, such as micronutrients or carcinogenic compounds, may provide objective and quantitative information for an individual's exposure to these chemicals. Moreover, critically important exposure information of carcinogenic chemicals or oxidative stress, namely level of DNA adducts, may be available using blood cell components. Further information on genetic polymorphism of metabolizing or repair enzyme using blood cell components will contribute to the investigation on gene-environment interactions.
Fifth, vital status is followed not only for those who remain living in the study area, but also for those who outmigrated from the study area, by individually asking local governments where the subjects have migrated to. This is especially important where migration rate is high.
Sixth, a questionnaire will be distributed at least three times for the fixed cohort. This will allow us to collect data on changing lifestyle and disease occurrence between the surveys.
Finally, a newsletter will be distributed to all study subjects during the follow-up period to inform them of the progress of the study. This will be important to keep the study subjects feeling actively involved in the study. Also, an outline of the JPHC Study has been posted on a website (http://www.east.ncc.go.jp/epi/jphc).
These unique features enable us to gather high-quality evidence, which will be essential to promote cancer and cardiovascular prevention strategies in Japan.
